Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Left Ventricular Assist Devices
GLP1-RA therapy in patients with advanced HF and LVADs is potentially associated with improved heart transplantation rates while decreasing hospitalization and acute HF event rates.
Authors
- Kwan Lee (ORCID: https://orcid.org/0000-0001-6302-9925)
- Beani Forst
- Hoang Nhat Pham (ORCID: https://orcid.org/0000-0001-8412-0082)
- George Bcharah (ORCID: https://orcid.org/0009-0009-9296-2824)
- Mahmoud Hassan Abdelnabi (ORCID: https://orcid.org/0000-0001-8016-9049)
- Ramzi Ibrahim (ORCID: https://orcid.org/0000-0003-0124-9513)
- Timothy Barry (ORCID: https://orcid.org/0000-0002-0576-2990)
- Juan Farina (ORCID: https://orcid.org/0000-0002-5824-8485)
- Mohamed Allam (ORCID: https://orcid.org/0000-0002-7687-9344)
- Chadi Ayoub (ORCID: https://orcid.org/0000-0001-5877-7478)
- Gerald Lim
- Reza Arsanjani
- Xuan Ci Mee (ORCID: https://orcid.org/0009-0005-3878-5506)
Institutions
- University of Arizona (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1002/ehf2.15379
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00